bluuebunny/crossref_metadata_2025 huggingface dataset:
Supplementary Table S3 from Durable Suppression of Acquired MEK Inhibitor Resistance in Cancer by Sequestering MEK from ERK and Promoting Antitumor T-cell Immunity
Authors: Hong Aayoung , Piva Marco , Liu Sixue , Hugo Willy , Lomeli Shirley H. , Zoete Vincent , Randolph Christopher E. , Yang Zhentao , Wang Yan , Lee Jordan J. , Lo Skylar J. , Sun Lu , Vega-Crespo Agustin , Garcia Alejandro J. , Shackelford David B. , Dubinett Steven M. , Scumpia Philip O. , Byrum Stephanie D. , Tackett Alan J. , Donahue Timothy R. , Michielin Olivier , Holmen Sheri L. , Ribas Antoni , Moriceau Gatien , Lo Roger S.
Published: April 2023

Supplementary Table S3
Supplementary Table S2 from Durable Suppression of Acquired MEK Inhibitor Resistance in Cancer by Sequestering MEK from ERK and Promoting Antitumor T-cell Immunity
Authors: Hong Aayoung , Piva Marco , Liu Sixue , Hugo Willy , Lomeli Shirley H. , Zoete Vincent , Randolph Christopher E. , Yang Zhentao , Wang Yan , Lee Jordan J. , Lo Skylar J. , Sun Lu , Vega-Crespo Agustin , Garcia Alejandro J. , Shackelford David B. , Dubinett Steven M. , Scumpia Philip O. , Byrum Stephanie D. , Tackett Alan J. , Donahue Timothy R. , Michielin Olivier , Holmen Sheri L. , Ribas Antoni , Moriceau Gatien , Lo Roger S.
Published: April 2023

Supplementary Table S2
Supplementary Table S1 from Durable Suppression of Acquired MEK Inhibitor Resistance in Cancer by Sequestering MEK from ERK and Promoting Antitumor T-cell Immunity
Authors: Hong Aayoung , Piva Marco , Liu Sixue , Hugo Willy , Lomeli Shirley H. , Zoete Vincent , Randolph Christopher E. , Yang Zhentao , Wang Yan , Lee Jordan J. , Lo Skylar J. , Sun Lu , Vega-Crespo Agustin , Garcia Alejandro J. , Shackelford David B. , Dubinett Steven M. , Scumpia Philip O. , Byrum Stephanie D. , Tackett Alan J. , Donahue Timothy R. , Michielin Olivier , Holmen Sheri L. , Ribas Antoni , Moriceau Gatien , Lo Roger S.
Published: April 2023

Supplementary Table S1
Supplementary Data from Durable Suppression of Acquired MEK Inhibitor Resistance in Cancer by Sequestering MEK from ERK and Promoting Antitumor T-cell Immunity
Authors: Hong Aayoung , Piva Marco , Liu Sixue , Hugo Willy , Lomeli Shirley H. , Zoete Vincent , Randolph Christopher E. , Yang Zhentao , Wang Yan , Lee Jordan J. , Lo Skylar J. , Sun Lu , Vega-Crespo Agustin , Garcia Alejandro J. , Shackelford David B. , Dubinett Steven M. , Scumpia Philip O. , Byrum Stephanie D. , Tackett Alan J. , Donahue Timothy R. , Michielin Olivier , Holmen Sheri L. , Ribas Antoni , Moriceau Gatien , Lo Roger S.
Published: April 2023

Supplementary Figures, Figure Legends, and Table Legends
Supplementary Table 4 from Targeting Mitochondrial Structure Sensitizes Acute Myeloid Leukemia to Venetoclax Treatment
Authors: Chen Xufeng , Glytsou Christina , Zhou Hua , Narang Sonali , Reyna Denis E. , Lopez Andrea , Sakellaropoulos Theodore , Gong Yixiao , Kloetgen Andreas , Yap Yoon Sing , Wang Eric , Gavathiotis Evripidis , Tsirigos Aristotelis , Tibes Raoul , Aifantis Iannis
Published: April 2023

sgRNA guide sequences, shRNA sequences and qPCR primers used in this study
Supplementary Table 3 from Targeting Mitochondrial Structure Sensitizes Acute Myeloid Leukemia to Venetoclax Treatment
Authors: Chen Xufeng , Glytsou Christina , Zhou Hua , Narang Sonali , Reyna Denis E. , Lopez Andrea , Sakellaropoulos Theodore , Gong Yixiao , Kloetgen Andreas , Yap Yoon Sing , Wang Eric , Gavathiotis Evripidis , Tsirigos Aristotelis , Tibes Raoul , Aifantis Iannis
Published: April 2023

Relative quantification of metabolites in the hybrid panel in CLPB knockout MOLM-13
Supplementary Table 1 from Targeting Mitochondrial Structure Sensitizes Acute Myeloid Leukemia to Venetoclax Treatment
Authors: Chen Xufeng , Glytsou Christina , Zhou Hua , Narang Sonali , Reyna Denis E. , Lopez Andrea , Sakellaropoulos Theodore , Gong Yixiao , Kloetgen Andreas , Yap Yoon Sing , Wang Eric , Gavathiotis Evripidis , Tsirigos Aristotelis , Tibes Raoul , Aifantis Iannis
Published: April 2023

Raw counts and gene-based CRISPR score analysis of the genome wide CRIPR/Cas9 loss-of-function screen
Supplementary Figures and Figure Legends from Targeting Mitochondrial Structure Sensitizes Acute Myeloid Leukemia to Venetoclax Treatment
Authors: Chen Xufeng , Glytsou Christina , Zhou Hua , Narang Sonali , Reyna Denis E. , Lopez Andrea , Sakellaropoulos Theodore , Gong Yixiao , Kloetgen Andreas , Yap Yoon Sing , Wang Eric , Gavathiotis Evripidis , Tsirigos Aristotelis , Tibes Raoul , Aifantis Iannis
Published: April 2023

Supplementary Figures and Figure Legends
Figure S4 from Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11
Authors: Lang Xueting , Green Michael D. , Wang Weimin , Yu Jiali , Choi Jae Eun , Jiang Long , Liao Peng , Zhou Jiajia , Zhang Qiang , Dow Ania , Saripalli Anjali L. , Kryczek Ilona , Wei Shuang , Szeliga Wojciech , Vatan Linda , Stone Everett M. , Georgiou George , Cieslik Marcin , Wahl Daniel R. , Morgan Meredith A. , Chinnaiyan Arul M. , Lawrence Theodore S. , Zou Weiping
Published: April 2023

Figure S4 shows that radiotherapy and immunotherapy can synergistically induce tumoral ferroptosis
Figure S3 from Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11
Authors: Lang Xueting , Green Michael D. , Wang Weimin , Yu Jiali , Choi Jae Eun , Jiang Long , Liao Peng , Zhou Jiajia , Zhang Qiang , Dow Ania , Saripalli Anjali L. , Kryczek Ilona , Wei Shuang , Szeliga Wojciech , Vatan Linda , Stone Everett M. , Georgiou George , Cieslik Marcin , Wahl Daniel R. , Morgan Meredith A. , Chinnaiyan Arul M. , Lawrence Theodore S. , Zou Weiping
Published: April 2023

Figure S3 shows that radiotherapy and IFNgamma can synergistically downregulate SLC7A11 expression in tumor cells
Figure S2 from Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11
Authors: Lang Xueting , Green Michael D. , Wang Weimin , Yu Jiali , Choi Jae Eun , Jiang Long , Liao Peng , Zhou Jiajia , Zhang Qiang , Dow Ania , Saripalli Anjali L. , Kryczek Ilona , Wei Shuang , Szeliga Wojciech , Vatan Linda , Stone Everett M. , Georgiou George , Cieslik Marcin , Wahl Daniel R. , Morgan Meredith A. , Chinnaiyan Arul M. , Lawrence Theodore S. , Zou Weiping
Published: April 2023

Figure S2 shows that CD8+ T cells can promote radiotherapy induced ferroptosis via secreting IFNgamma
Table S4 from A TLR3 Ligand Reestablishes Chemotherapeutic Responses in the Context of FPR1 Deficiency
Authors: Le Naour Julie , Liu Peng , Zhao Liwei , Adjemian Sandy , Sztupinszki Zsofia , Taieb Julien , Mulot Claire , Silvin Aymeric , Dutertre Charles-Antoine , Ginhoux Florent , Sauvat Allan , Cerrato Giulia , Castoldi Francesca , Martins Isabelle , Stoll Gautier , Paillet Juliette , Mangane Khady , Richter Cornelia , Kepp Oliver , Maiuri Maria Chiara , Pietrocola Federico , Vandenabeele Peter , André Fabrice , Delaloge Suzette , Szallasi Zoltan , Laurent-Puig Pierre , Zucman-Rossi Jessica , Zitvogel Laurence , Pol Jonathan G. , Vacchelli Erika , Kroemer Guido
Published: April 2023

Table S4
Supplementary Table S2 from Integrative Bulk and Single-Cell Profiling of Premanufacture T-cell Populations Reveals Factors Mediating Long-Term Persistence of CAR T-cell Therapy
Authors: Chen Gregory M. , Chen Changya , Das Rajat K. , Gao Peng , Chen Chia-Hui , Bandyopadhyay Shovik , Ding Yang-Yang , Uzun Yasin , Yu Wenbao , Zhu Qin , Myers Regina M. , Grupp Stephan A. , Barrett David M. , Tan Kai
Published: April 2023

Supplementary Table S2. Differentially expressed genes between T-cell subtypes and clinical CAR T-cell persistence groups. Differential expression analysis was performed on RNA-Seq data with Limma. The first sheet contains genes ranked by p-value from the ANOVA model with the null hypothesis of equal expression across the five T-cell subsets. Subsequent sheets show the output of a mixed effects model including T-cell subtype and clinical CAR Tcell persistence group. Sheets 2-10 consist of comparisons between T-cell subsets, and sheets 11- 19 consist of comparisons between patients with long ({greater than or equal to} 6 month) vs short (< 6 month) CAR Tcell persistence.
Supplementary Materials and Methods from Oncogenic KRAS Recruits an Expansive Transcriptional Network through Mutant p53 to Drive Pancreatic Cancer Metastasis
Authors: Kim Michael P. , Li Xinqun , Deng Jenying , Zhang Yun , Dai Bingbing , Allton Kendra L. , Hughes Tara G. , Siangco Christian , Augustine Jithesh J. , Kang Ya'an , McDaniel Joy M. , Xiong Shunbin , Koay Eugene J. , McAllister Florencia , Bristow Christopher A. , Heffernan Timothy P. , Maitra Anirban , Liu Bin , Barton Michelle C. , Wasylishen Amanda R. , Fleming Jason B. , Lozano Guillermina
Published: April 2023

Supplementary Materials and Methods
Supplementary Table S4 from Discovery of Candidate DNA Methylation Cancer Driver Genes
Authors: Pan Heng , Renaud Loïc , Chaligne Ronan , Bloehdorn Johannes , Tausch Eugen , Mertens Daniel , Fink Anna Maria , Fischer Kirsten , Zhang Chao , Betel Doron , Gnirke Andreas , Imielinski Marcin , Moreaux Jérôme , Hallek Michael , Meissner Alexander , Stilgenbauer Stephan , Wu Catherine J. , Elemento Olivier , Landau Dan A.
Published: April 2023

Copy number changes in MethSig CLL DNAme drivers.
Supplementary Table S1 from Discovery of Candidate DNA Methylation Cancer Driver Genes
Authors: Pan Heng , Renaud Loïc , Chaligne Ronan , Bloehdorn Johannes , Tausch Eugen , Mertens Daniel , Fink Anna Maria , Fischer Kirsten , Zhang Chao , Betel Doron , Gnirke Andreas , Imielinski Marcin , Moreaux Jérôme , Hallek Michael , Meissner Alexander , Stilgenbauer Stephan , Wu Catherine J. , Elemento Olivier , Landau Dan A.
Published: April 2023

Sequencing metrics of RRBS data.
Supplementary Table S3 from Simultaneous Inhibition of LSD1 and TGFβ Enables Eradication of Poorly Immunogenic Tumors with Anti–PD-1 Treatment
Authors: Sheng Wanqiang , Liu Yi , Chakraborty Damayanti , Debo Brian , Shi Yang
Published: April 2023

DNA oligo sequences
Supplementary Figures S1-S11 from Simultaneous Inhibition of LSD1 and TGFβ Enables Eradication of Poorly Immunogenic Tumors with Anti–PD-1 Treatment
Authors: Sheng Wanqiang , Liu Yi , Chakraborty Damayanti , Debo Brian , Shi Yang
Published: April 2023

Supplementary Figures S1-S11 combined in a single pdf file
Supplementary Figure Legend from GITR Pathway Activation Abrogates Tumor Immune Suppression through Loss of Regulatory T-cell Lineage Stability
Authors: Schaer David A. , Budhu Sadna , Liu Cailian , Bryson Campbell , Malandro Nicole , Cohen Adam , Zhong Hong , Yang Xia , Houghton Alan N. , Merghoub Taha , Wolchok Jedd D.
Published: April 2023

PDF file - 48K
Supplementary Figure 1 from GITR Pathway Activation Abrogates Tumor Immune Suppression through Loss of Regulatory T-cell Lineage Stability
Authors: Schaer David A. , Budhu Sadna , Liu Cailian , Bryson Campbell , Malandro Nicole , Cohen Adam , Zhong Hong , Yang Xia , Houghton Alan N. , Merghoub Taha , Wolchok Jedd D.
Published: April 2023

PDF file - 143K, Foxp3 loss in Tregs is tumor and DTA-1 dose dependent
Supplementary Table 3 from NY-ESO-1 Expression in Meningioma Suggests a Rationale for New Immunotherapeutic Approaches
Authors: Baia Gilson S. , Caballero Otavia L. , Ho Janelle S.Y. , Zhao Qi , Cohen Tzeela , Binder Zev A. , Salmasi Vafi , Gallia Gary L. , Quinones-Hinojosa Alfredo , Olivi Alessandro , Brem Henry , Burger Peter , Strausberg Robert L. , Simpson Andrew J.G. , Eberhart Charles G. , Riggins Gregory J.
Published: April 2023

XLSX file - 26K, Analysis for Reactivity to NY-ESO-1 Protein by ELISA in Meningioma Serum Samples.
Supplementary Table 2 from NY-ESO-1 Expression in Meningioma Suggests a Rationale for New Immunotherapeutic Approaches
Authors: Baia Gilson S. , Caballero Otavia L. , Ho Janelle S.Y. , Zhao Qi , Cohen Tzeela , Binder Zev A. , Salmasi Vafi , Gallia Gary L. , Quinones-Hinojosa Alfredo , Olivi Alessandro , Brem Henry , Burger Peter , Strausberg Robert L. , Simpson Andrew J.G. , Eberhart Charles G. , Riggins Gregory J.
Published: April 2023

XLSX file - 22K, Clinical Variables of Meningioma Cases and Summary of the Immunohistochemistry Results Stratified by Grade.
Supplementary Methods from NY-ESO-1 Expression in Meningioma Suggests a Rationale for New Immunotherapeutic Approaches
Authors: Baia Gilson S. , Caballero Otavia L. , Ho Janelle S.Y. , Zhao Qi , Cohen Tzeela , Binder Zev A. , Salmasi Vafi , Gallia Gary L. , Quinones-Hinojosa Alfredo , Olivi Alessandro , Brem Henry , Burger Peter , Strausberg Robert L. , Simpson Andrew J.G. , Eberhart Charles G. , Riggins Gregory J.
Published: April 2023

PDF file - 97K
Supplementary Figure Legend from NY-ESO-1 Expression in Meningioma Suggests a Rationale for New Immunotherapeutic Approaches
Authors: Baia Gilson S. , Caballero Otavia L. , Ho Janelle S.Y. , Zhao Qi , Cohen Tzeela , Binder Zev A. , Salmasi Vafi , Gallia Gary L. , Quinones-Hinojosa Alfredo , Olivi Alessandro , Brem Henry , Burger Peter , Strausberg Robert L. , Simpson Andrew J.G. , Eberhart Charles G. , Riggins Gregory J.
Published: April 2023

PDF file - 102K
Supplementary Figure Legends from Nature of Tumor Control by Permanently and Transiently Modified GD2 Chimeric Antigen Receptor T Cells in Xenograft Models of Neuroblastoma
Authors: Singh Nathan , Liu Xiaojun , Hulitt Jessica , Jiang Shuguang , June Carl H. , Grupp Stephan A. , Barrett David M. , Zhao Yangbing
Published: April 2023

Supplementary Figure Legends from Nature of Tumor Control by Permanently and Transiently Modified GD2 Chimeric Antigen Receptor T Cells in Xenograft Models of Neuroblastoma
Supplemental Figure 2 from Nature of Tumor Control by Permanently and Transiently Modified GD2 Chimeric Antigen Receptor T Cells in Xenograft Models of Neuroblastoma
Authors: Singh Nathan , Liu Xiaojun , Hulitt Jessica , Jiang Shuguang , June Carl H. , Grupp Stephan A. , Barrett David M. , Zhao Yangbing
Published: April 2023

Growth of T cells engineered with lentivirus or RNA.
Supplemental Figure 1 from Nature of Tumor Control by Permanently and Transiently Modified GD2 Chimeric Antigen Receptor T Cells in Xenograft Models of Neuroblastoma
Authors: Singh Nathan , Liu Xiaojun , Hulitt Jessica , Jiang Shuguang , June Carl H. , Grupp Stephan A. , Barrett David M. , Zhao Yangbing
Published: April 2023

Bioluminescent xenograft model of disseminated neuroblastoma.
Supplementary Figure 3 from Phosphatidylserine-Targeting Antibody Induces M1 Macrophage Polarization and Promotes Myeloid-Derived Suppressor Cell Differentiation
Authors: Yin Yi , Huang Xianming , Lynn Kristi D. , Thorpe Philip E.
Published: April 2023

PDF file - 1075K, TAMs in LNCaP tumors switch polarity from an M2-like phenotype to an M1-like phenotype after 2aG4 treatment.
Supplementary Figure 2 from Phosphatidylserine-Targeting Antibody Induces M1 Macrophage Polarization and Promotes Myeloid-Derived Suppressor Cell Differentiation
Authors: Yin Yi , Huang Xianming , Lynn Kristi D. , Thorpe Philip E.
Published: April 2023

PDF file - 1565K, Damage to tumor vasculature in LNCaP tumors induced by treatment with 2aG4.
Table S1-S3; Figure S1-S13 from BET Bromodomain Inhibition Cooperates with PD-1 Blockade to Facilitate Antitumor Response in Kras-Mutant Non–Small Cell Lung Cancer
Authors: Adeegbe Dennis O. , Liu Shengwu , Hattersley Maureen M. , Bowden Michaela , Zhou Chensheng W. , Li Shuai , Vlahos Raven , Grondine Michael , Dolgalev Igor , Ivanova Elena V. , Quinn Max M. , Gao Peng , Hammerman Peter S. , Bradner James E. , Diehl J. Alan , Rustgi Anil K. , Bass Adam J. , Tsirigos Aristotelis , Freeman Gordon J. , Chen Huawei , Wong Kwok-Kin
Published: April 2023

Supplementary Table S1. Detailed information about the antibodies used. Supplementary Table S2. Proportions of listed immune cell subsets in the tumor microenvironment of NSCLC GEMs were evaluated by FACS utilizing indicated lineage markers and proteins. Supplementary Table S3. Tumor cells from treated KP mice were subjected to RNA-sequencing. Supplementary Figure S1. Kinetics of tumor growth in KP mice treated with anti-PD-1. Supplementary Figure S2. Immune cell proportions in the tumors of treated KP mice. Supplementary Figure S3. PD-1 is prominently expressed on tumor-infiltrating T cells in GEMM of NSCLC. Supplementary Figure S4. Decreased expression of PD-1 and CTLA-4 on tumor-infiltrating CD4+ T cells under JQ1 treatment. Supplementary Figure S5. Increased expression of MHC class I on tumor-infiltrating tumor-associated macrophages (TAMs). Supplementary Figure S6. Combination of JQ1 and PD-1 blockade evokes unique genomic genomic changes in tumors of treated KP mice. Supplementary Figure S7. Overall survival of tumor-bearing nude mice treated with JQ1 or anti-PD-1. Supplementary Figure S8. JQ1 and/or anti-PD-1 treatment facilitated enhanced effector function of tumor-infiltrating CD8+ T cells. Supplementary Figure S9. Combination of JQ1 and α-PD-1 did not have substantial deleterious effects on tumor-associated T cells. Supplementary Figure S10. Tumor-infiltrating KLRG1+ CD4+Foxp3+ Tregs exhibit a highly activated profile but resemble natural peripheral Tregs. Supplementary Figure S11. Tumor-infiltrating KLRG1+ CD4+Foxp3+ Tregs are not derived from CD4+CD25- cells. Supplementary Figure S12. Tumor-associated KLRG1+ Tregs express higher CTLA-4 and demonstrate enhanced suppressive function. Supplementary Figure S13. Decreased expression of Treg signature proteins and Bcl-2 on tumor-infiltrating KLRG1+ Treg subset under JQ1 treatment.
Supplementary Figures from Sustained Persistence of IL2 Signaling Enhances the Antitumor Effect of Peptide Vaccines through T-cell Expansion and Preventing PD-1 Inhibition
Authors: Sultan Hussein , Kumai Takumi , Fesenkova Valentyna I. , Fan Aaron E. , Wu Juan , Cho Hyun-Il , Kobayashi Hiroya , Harabuchi Yasuaki , Celis Esteban
Published: April 2023

S1. Poly-IC is a weaker adjuvant than poly-ICLC but IL2Cx improves its activity. S2. BiVax/IL2Cx generates large T cell responses in BALB/c mice. S3. Human IL2Cx has similar adjuvant effect to mouse IL2Cx. S4. WT mice were vaccinated with BiVax prime and 5 days later mice were boosted with pamTrp1/poly-IC (BiVax), IL2Cx25 alone, pamTrp1/IL2Cx25 or BiVax/IL2Cx25 and on day 12 the numbers of Tregs (CD4+ CD25+ Foxp3+) were evaluated in spleens. (N= 3 mice/group). S5. Antitumor effects BiVax/IL2Cx in BALB/c mice. S6. A-B, WT B6 mice received a BiVax prime followed by BiVax/IL2Cx122 boost. S7. A, WT mice were vaccinated with pamTrp1/poly-IC (BiVax), prime and 5 days later mice were boosted with either BiVax, BiVax + HD-IL2 (600,000 I.U 2X/day for 3 consecutive days), or BiVax + PEG-IL2 and on day 12 the numbers of Trp1+ T cells were evaluated in spleens. B, CD45.1 WT mice were adoptively transferred with TgTR1 CD8 T cells followed with pamTrp1/poly-IC (BiVax) prime and 5 days later mice were boosted with either BiVax, BiVax + HD-IL2 or BiVax + PEG-IL2. One hour after the last dose of IL2, pSTAT5 expression was evaluated in TgTR1 T cells from the spleens. (N= 3 mice/group). S8. Tumor cells isolated from tumor bearing mice express MHC-I and can stimulate CD8 T cells.
Supplementary Figure 6 from c-Abl Modulates Tumor Cell Sensitivity to Antibody-Dependent Cellular Cytotoxicity
Authors: Murray Joseph C. , Aldeghaither Dalal , Wang Shangzi , Nasto Rochelle E. , Jablonski Sandra A. , Tang Yong , Weiner Louis M.
Published: April 2023

Inhibition of c-Abl kinase activity by imatinib and sensitivity of HNSCC cell lines to ADCC.
Supplementary Figure 5 from c-Abl Modulates Tumor Cell Sensitivity to Antibody-Dependent Cellular Cytotoxicity
Authors: Murray Joseph C. , Aldeghaither Dalal , Wang Shangzi , Nasto Rochelle E. , Jablonski Sandra A. , Tang Yong , Weiner Louis M.
Published: April 2023

Effect of various c-Abl tyrosine kinase inhibitors on ADCC.
Supplementary Figure 4 from c-Abl Modulates Tumor Cell Sensitivity to Antibody-Dependent Cellular Cytotoxicity
Authors: Murray Joseph C. , Aldeghaither Dalal , Wang Shangzi , Nasto Rochelle E. , Jablonski Sandra A. , Tang Yong , Weiner Louis M.
Published: April 2023

EGFR surface expression after knockdown of ABL1 or imatinib treatment in A431 cells.
Supplementary Figure 2 from c-Abl Modulates Tumor Cell Sensitivity to Antibody-Dependent Cellular Cytotoxicity
Authors: Murray Joseph C. , Aldeghaither Dalal , Wang Shangzi , Nasto Rochelle E. , Jablonski Sandra A. , Tang Yong , Weiner Louis M.
Published: April 2023

Differential cytotoxicity from primary screens and specific lysis and differential cytotoxicity from secondary screens.
Supplementay Figures S1-3 from Tumor PDCD1LG2 (PD-L2) Expression and the Lymphocytic Reaction to Colorectal Cancer
Authors: Masugi Yohei , Nishihara Reiko , Hamada Tsuyoshi , Song Mingyang , da Silva Annacarolina , Kosumi Keisuke , Gu Mancang , Shi Yan , Li Wanwan , Liu Li , Nevo Daniel , Inamura Kentaro , Cao Yin , Liao Xiaoyun , Nosho Katsuhiko , Chan Andrew T. , Giannakis Marios , Bass Adam J. , Hodi F. Stephen , Freeman Gordon J. , Rodig Scott J. , Fuchs Charles S. , Qian Zhi Rong , Nowak Jonathan A. , Ogino Shuji
Published: April 2023

Supplementary Figure S1. Flow diagram of the study population in the Nurses'' Health Study and the Health Professionals Follow-Up Study. Supplementary Figure S2. Immunohistochemistry of a colorectal carcinoma case using anti-PDCD1LG2 (PD-L2) antibody (A) and its isotype control (B). Supplementary Figure S3. Kaplan-Meier curves for colorectal cancer-specific mortality (A) and overall mortality (B) according to tumor PDCD1LG2 (PD-L2) expression.
Supplementary Table S6. from Tumor PDCD1LG2 (PD-L2) Expression and the Lymphocytic Reaction to Colorectal Cancer
Authors: Masugi Yohei , Nishihara Reiko , Hamada Tsuyoshi , Song Mingyang , da Silva Annacarolina , Kosumi Keisuke , Gu Mancang , Shi Yan , Li Wanwan , Liu Li , Nevo Daniel , Inamura Kentaro , Cao Yin , Liao Xiaoyun , Nosho Katsuhiko , Chan Andrew T. , Giannakis Marios , Bass Adam J. , Hodi F. Stephen , Freeman Gordon J. , Rodig Scott J. , Fuchs Charles S. , Qian Zhi Rong , Nowak Jonathan A. , Ogino Shuji
Published: April 2023

Crohn's-like lymphoid reaction and colorectal cancer mortality
Supplementary Table S5. from Tumor PDCD1LG2 (PD-L2) Expression and the Lymphocytic Reaction to Colorectal Cancer
Authors: Masugi Yohei , Nishihara Reiko , Hamada Tsuyoshi , Song Mingyang , da Silva Annacarolina , Kosumi Keisuke , Gu Mancang , Shi Yan , Li Wanwan , Liu Li , Nevo Daniel , Inamura Kentaro , Cao Yin , Liao Xiaoyun , Nosho Katsuhiko , Chan Andrew T. , Giannakis Marios , Bass Adam J. , Hodi F. Stephen , Freeman Gordon J. , Rodig Scott J. , Fuchs Charles S. , Qian Zhi Rong , Nowak Jonathan A. , Ogino Shuji
Published: April 2023

Ordinal logistic regression analysis to assess the association of tumor PDCD1LG2 (PD-L2) expression (predictor) with the overall lymphocytic reaction score (outcome)
Supplementary Table S4 from Tumor PDCD1LG2 (PD-L2) Expression and the Lymphocytic Reaction to Colorectal Cancer
Authors: Masugi Yohei , Nishihara Reiko , Hamada Tsuyoshi , Song Mingyang , da Silva Annacarolina , Kosumi Keisuke , Gu Mancang , Shi Yan , Li Wanwan , Liu Li , Nevo Daniel , Inamura Kentaro , Cao Yin , Liao Xiaoyun , Nosho Katsuhiko , Chan Andrew T. , Giannakis Marios , Bass Adam J. , Hodi F. Stephen , Freeman Gordon J. , Rodig Scott J. , Fuchs Charles S. , Qian Zhi Rong , Nowak Jonathan A. , Ogino Shuji
Published: April 2023

Distribution of colorectal cancer cases according to tumor PDCD1LG2 (PD-L2) expression and the overall lymphocytic reaction score
Supplementary Table S2 from Tumor PDCD1LG2 (PD-L2) Expression and the Lymphocytic Reaction to Colorectal Cancer
Authors: Masugi Yohei , Nishihara Reiko , Hamada Tsuyoshi , Song Mingyang , da Silva Annacarolina , Kosumi Keisuke , Gu Mancang , Shi Yan , Li Wanwan , Liu Li , Nevo Daniel , Inamura Kentaro , Cao Yin , Liao Xiaoyun , Nosho Katsuhiko , Chan Andrew T. , Giannakis Marios , Bass Adam J. , Hodi F. Stephen , Freeman Gordon J. , Rodig Scott J. , Fuchs Charles S. , Qian Zhi Rong , Nowak Jonathan A. , Ogino Shuji
Published: April 2023

Clinical, pathological, and molecular features according to stromal PDCD1LG2 (PD-L2) expression in colorectal cancer tissues
Supplementary Table S1 from Tumor PDCD1LG2 (PD-L2) Expression and the Lymphocytic Reaction to Colorectal Cancer
Authors: Masugi Yohei , Nishihara Reiko , Hamada Tsuyoshi , Song Mingyang , da Silva Annacarolina , Kosumi Keisuke , Gu Mancang , Shi Yan , Li Wanwan , Liu Li , Nevo Daniel , Inamura Kentaro , Cao Yin , Liao Xiaoyun , Nosho Katsuhiko , Chan Andrew T. , Giannakis Marios , Bass Adam J. , Hodi F. Stephen , Freeman Gordon J. , Rodig Scott J. , Fuchs Charles S. , Qian Zhi Rong , Nowak Jonathan A. , Ogino Shuji
Published: April 2023

Multivariable ordinal logistic regression analysis to calculate adjusted OR for associations of variables with tumor PDCD1LG2 (PD-L2) expression (outcome) in colorectal cancer
Supplementary Figure Legend from CD4 T Cells Require ICOS-Mediated PI3K Signaling to Increase T-Bet Expression in the Setting of Anti-CTLA-4 Therapy
Authors: Chen Hong , Fu Tihui , Suh Woong-Kyung , Tsavachidou Dimitra , Wen Sijin , Gao Jianjun , Ng Tang Derek , He Qiuming , Sun Jingjing , Sharma Padmanee
Published: April 2023

PDF file - 63K
Supplementary Methods from PARP1 Suppresses the Transcription of PD-L1 by Poly(ADP-Ribosyl)ating STAT3
Authors: Ding Ling , Chen Xi , Xu Xiaqing , Qian Yuli , Liang Guikai , Yao Fengqi , Yao Zhangting , Wu Honghai , Zhang Jieqiong , He Qiaojun , Yang Bo
Published: April 2023

Sequences and primers used in experiment.
Figure S6 from PARP1 Suppresses the Transcription of PD-L1 by Poly(ADP-Ribosyl)ating STAT3
Authors: Ding Ling , Chen Xi , Xu Xiaqing , Qian Yuli , Liang Guikai , Yao Fengqi , Yao Zhangting , Wu Honghai , Zhang Jieqiong , He Qiaojun , Yang Bo
Published: April 2023

Various cancer cells are transfected with PARP1 siRNA, and the phosphorylation of STAT3 was upregulated.
Figure S5 from PARP1 Suppresses the Transcription of PD-L1 by Poly(ADP-Ribosyl)ating STAT3
Authors: Ding Ling , Chen Xi , Xu Xiaqing , Qian Yuli , Liang Guikai , Yao Fengqi , Yao Zhangting , Wu Honghai , Zhang Jieqiong , He Qiaojun , Yang Bo
Published: April 2023

Increased PD-L1 expression is associated with enhanced STAT3 phosphorylation.
Figure S3 from PARP1 Suppresses the Transcription of PD-L1 by Poly(ADP-Ribosyl)ating STAT3
Authors: Ding Ling , Chen Xi , Xu Xiaqing , Qian Yuli , Liang Guikai , Yao Fengqi , Yao Zhangting , Wu Honghai , Zhang Jieqiong , He Qiaojun , Yang Bo
Published: April 2023

PARR inhibitors do not affect cell viability or cell death in the concentrations used in current study.
Figure S2 from PARP1 Suppresses the Transcription of PD-L1 by Poly(ADP-Ribosyl)ating STAT3
Authors: Ding Ling , Chen Xi , Xu Xiaqing , Qian Yuli , Liang Guikai , Yao Fengqi , Yao Zhangting , Wu Honghai , Zhang Jieqiong , He Qiaojun , Yang Bo
Published: April 2023

PARP inhibitors upregulate the protein level of PD-L1.
Supplementary Figures from Tumor Microenvironment Characterization in Gastric Cancer Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures
Authors: Zeng Dongqiang , Li Meiyi , Zhou Rui , Zhang Jingwen , Sun Huiying , Shi Min , Bin Jianping , Liao Yulin , Rao Jinjun , Liao Wangjun
Published: April 2023

Figure S1. Overview of study design and TME phenotypes of 1524 gastric cancer patients; Figure S2. Consensus clustering of TME cell infiltration in ACRG cohort, fractions of cells in three TME phenotypes, and DEGs among the TME phenotypes; Figure S3. The functional annotation of TME signature; Figure S4. Validation of TME signature characteristics with TME cell infiltrating patterns; Figure S5. The cytokine and chemokine milieu among Gene-clusters, correlation between TMEscore and gene signatures, and prognostic value of TMEscore; Figure S6. Prognostic value of TMEscore in gastric cancer cohorts; Figure S7. The biological characteristics and predictive value of TMEscore
Supplementary Methods from Targeting Fibroblast Activation Protein in Tumor Stroma with Chimeric Antigen Receptor T Cells Can Inhibit Tumor Growth and Augment Host Immunity without Severe Toxicity
Authors: Wang Liang-Chuan S. , Lo Albert , Scholler John , Sun Jing , Majumdar Rajrupa S. , Kapoor Veena , Antzis Michael , Cotner Cody E. , Johnson Laura A. , Durham Amy C. , Solomides Charalambos C. , June Carl H. , Puré Ellen , Albelda Steven M.
Published: April 2023

PDF file - 135K
Supplementary Figure Legend from Targeting Fibroblast Activation Protein in Tumor Stroma with Chimeric Antigen Receptor T Cells Can Inhibit Tumor Growth and Augment Host Immunity without Severe Toxicity
Authors: Wang Liang-Chuan S. , Lo Albert , Scholler John , Sun Jing , Majumdar Rajrupa S. , Kapoor Veena , Antzis Michael , Cotner Cody E. , Johnson Laura A. , Durham Amy C. , Solomides Charalambos C. , June Carl H. , Puré Ellen , Albelda Steven M.
Published: April 2023

PDF file - 135K
Supplementary Figure 4 from PD-L1 Expression in Triple-Negative Breast Cancer
Authors: Mittendorf Elizabeth A. , Philips Anne V. , Meric-Bernstam Funda , Qiao Na , Wu Yun , Harrington Susan , Su Xiaoping , Wang Ying , Gonzalez-Angulo Ana M. , Akcakanat Argun , Chawla Akhil , Curran Michael , Hwu Patrick , Sharma Padmanee , Litton Jennifer K. , Molldrem Jeffrey J. , Alatrash Gheath
Published: April 2023

PDF file - 110K, Supplementary figure 4. T cell's undergo apoptosis after co-culture with MDA-MB-231 breast cancer cells following PTEN knockdown To determine the effect of increased PD-L1 cell surface expression on apoptosis, standard annexin V assays were performed. Anti-CD3/CD28-stimulated PBMC were co-cultured with breast cancer cells for 20 hours and then stained with anti-CD4 and anti-CD8 antibodies and resuspended in Annexin binding buffer. Analysis was performed using flow cytometry gating on CD4+ or CD8+ T cells. A representative histogram from one experiment is shown in panel A. The experiment was repeated three times in triplicate and the percent Annexin V positive CD4+ and CD8+ T cells from one experiment is shown in panel B.
Supplementary Figure 2 from PD-L1 Expression in Triple-Negative Breast Cancer
Authors: Mittendorf Elizabeth A. , Philips Anne V. , Meric-Bernstam Funda , Qiao Na , Wu Yun , Harrington Susan , Su Xiaoping , Wang Ying , Gonzalez-Angulo Ana M. , Akcakanat Argun , Chawla Akhil , Curran Michael , Hwu Patrick , Sharma Padmanee , Litton Jennifer K. , Molldrem Jeffrey J. , Alatrash Gheath
Published: April 2023

PDF file - 78K, Supplementary figure 2. T cell Proliferation is decreased after co-culture with MDA-MB-157 breast cancer cells following PTEN knockdown. (A) To determine the effect of the increased PD-L1 cell surface expression following PTEN knockdown on T cell proliferation, peripheral blood mononuclear cells (PBMC) from healthy donors were labeled with carboxyfluorescein succinimidyl ester (CFSE) and co-cultured with MDA-MB-231 breast cancer cells that were transduced with PTEN shRNA (i.e. increase surface PD-L1) or negative control groups including parental MDA-MB-231 cells or MDA-MB-231 cells transduced with non-targeting shRNA.. After stimulation with anti-CD3/CD28, proliferation was measured using flow cytometry. CFSE staining of CD4+ or CD8+T cells is shown in representative histograms from one replicate from one experiment. The experiment was performed three times in triplicate and the average percent proliferation ? SD for one experiment is shown in panel B. Unstimulated and anti-CD3/CD28 stimulated PBMC represent PBMC groups lacking MDA-MB-231 cells and were used as negative and positive controls, respectively. Significance was determined using an ANOVA test (*P<0.01)
Supplementary Figure S3 from Cell-free Tumor Microparticle Vaccines Stimulate Dendritic Cells via cGAS/STING Signaling
Authors: Zhang Huafeng , Tang Ke , Zhang Yi , Ma Ruihua , Ma Jingwei , Li Yong , Luo Shunqun , Liang Xiaoyu , Ji Tiantian , Gu Zhichao , Lu Jinzhi , He Wei , Cao Xuetao , Wan Yonghong , Huang Bo
Published: April 2023

Tumor cells-derived microparticles containing DNA activate DCs via cGAS-STING pathway.
Supplementary Figure S2 from Cell-free Tumor Microparticle Vaccines Stimulate Dendritic Cells via cGAS/STING Signaling
Authors: Zhang Huafeng , Tang Ke , Zhang Yi , Ma Ruihua , Ma Jingwei , Li Yong , Luo Shunqun , Liang Xiaoyu , Ji Tiantian , Gu Zhichao , Lu Jinzhi , He Wei , Cao Xuetao , Wan Yonghong , Huang Bo
Published: April 2023

Tumor cells-derived microparticles were efficiently taken up by DCs, resulting in T cells proliferation.
Supplementary Figure S1 from Cell-free Tumor Microparticle Vaccines Stimulate Dendritic Cells via cGAS/STING Signaling
Authors: Zhang Huafeng , Tang Ke , Zhang Yi , Ma Ruihua , Ma Jingwei , Li Yong , Luo Shunqun , Liang Xiaoyu , Ji Tiantian , Gu Zhichao , Lu Jinzhi , He Wei , Cao Xuetao , Wan Yonghong , Huang Bo
Published: April 2023

Tumor cells-derived microparticles are a highly effective and generally useful vaccination platform.
Supplementary Figure Legends from Cell-free Tumor Microparticle Vaccines Stimulate Dendritic Cells via cGAS/STING Signaling
Authors: Zhang Huafeng , Tang Ke , Zhang Yi , Ma Ruihua , Ma Jingwei , Li Yong , Luo Shunqun , Liang Xiaoyu , Ji Tiantian , Gu Zhichao , Lu Jinzhi , He Wei , Cao Xuetao , Wan Yonghong , Huang Bo
Published: April 2023

Supplementary Figure Legends
Supplementary figures 1-7 from Customized Viral Immunotherapy for HPV-Associated Cancer
Authors: Atherton Matthew J. , Stephenson Kyle B. , Pol Jonathan , Wang Fuan , Lefebvre Charles , Stojdl David F. , Nikota Jake K. , Dvorkin-Gheva Anna , Nguyen Andrew , Chen Lan , Johnson-Obaseki Stephanie , Villeneuve Patrick J. , Diallo Jean-Simon , Dimitroulakos Jim , Wan Yonghong , Lichty Brian D.
Published: April 2023

S1: RT-PCR confirms expression of E6 and E7 in TC1 S2: CD4+ T cell responses after E6E7 vaccination S3: E6E7 vaccination induces T-cell degranulation Tumor free S4: Tumor volume curves in E6E7 vaccinated mice S5: TCM frequency in mice after TC1 tumor clearance S6: PCA analysis of TC1 tumors S7: Images of MG1-GFP infected HPV+ primary tumor
CIR-17-0171 Supplementary Data from CD28 and 41BB Costimulation Enhances the Effector Function of CD19-Specific Engager T Cells
Authors: Velasquez Mireya Paulina , Szoor Arpad , Vaidya Abishek , Thakkar Aarohi , Nguyen Phuong , Wu Meng-Fen , Liu Hao , Gottschalk Stephen
Published: April 2023

S1: T-cell immunophenotyping by flow cytometry. S2: Determination of TSCM presence in PBMC and NT T-cells by flow cytometry. S3: CD19-ENGT-cells and CD19-ENGT-cells expressing CD80 and/or 41BBL kill Nalm 6 cells efficiently. S4: Experimental set up of Serial Killing Assay. S5: CD19- ENG.41BBL/CD80 T-cells have improved ability to sequentially kill CD19 target cells. S6: CD19-ENG T-cells expressing CD80 or 41BBL and CD80 have improved ability to sequentially kill CD19 target cells. S7: Nalm 6 express PD-L1 after exposure to IFNgamma. S8: CD19 ENG.41BBL/CD80 T-cells expand in vivo and persist long-term at low levels.
Supplementary Table S3 from MicroRNA MIR21 and T Cells in Colorectal Cancer
Authors: Mima Kosuke , Nishihara Reiko , Nowak Jonathan A. , Kim Sun A. , Song Mingyang , Inamura Kentaro , Sukawa Yasutaka , Masuda Atsuhiro , Yang Juhong , Dou Ruoxu , Nosho Katsuhiko , Baba Hideo , Giovannucci Edward L. , Bowden Michaela , Loda Massimo , Giannakis Marios , Bass Adam J. , Dranoff Glenn , Freeman Gordon J. , Chan Andrew T. , Fuchs Charles S. , Qian Zhi Rong , Ogino Shuji
Published: April 2023

The association of tumor MIR21 expression after adjusting for cellularity with the density of T-cells
Supplementary Table S2 from MicroRNA MIR21 and T Cells in Colorectal Cancer
Authors: Mima Kosuke , Nishihara Reiko , Nowak Jonathan A. , Kim Sun A. , Song Mingyang , Inamura Kentaro , Sukawa Yasutaka , Masuda Atsuhiro , Yang Juhong , Dou Ruoxu , Nosho Katsuhiko , Baba Hideo , Giovannucci Edward L. , Bowden Michaela , Loda Massimo , Giannakis Marios , Bass Adam J. , Dranoff Glenn , Freeman Gordon J. , Chan Andrew T. , Fuchs Charles S. , Qian Zhi Rong , Ogino Shuji
Published: April 2023

Final multivariable ordinal logistic regression models
Supplementary Figure Legends from Restoring Retinoic Acid Attenuates Intestinal Inflammation and Tumorigenesis in APCMin/+ Mice
Authors: Penny Hweixian Leong , Prestwood Tyler R. , Bhattacharya Nupur , Sun Fionna , Kenkel Justin A. , Davidson Matthew G. , Shen Lei , Zuniga Luis A. , Seeley E. Scott , Pai Reetesh , Choi Okmi , Tolentino Lorna , Wang Jinshan , Napoli Joseph L. , Engleman Edgar G.
Published: April 2023

Supplementary Figure Legends
Supplementary Figure 4 from Restoring Retinoic Acid Attenuates Intestinal Inflammation and Tumorigenesis in APCMin/+ Mice
Authors: Penny Hweixian Leong , Prestwood Tyler R. , Bhattacharya Nupur , Sun Fionna , Kenkel Justin A. , Davidson Matthew G. , Shen Lei , Zuniga Luis A. , Seeley E. Scott , Pai Reetesh , Choi Okmi , Tolentino Lorna , Wang Jinshan , Napoli Joseph L. , Engleman Edgar G.
Published: April 2023

RALDH1A2 in LPDCs from APCMin/+ and WT mice.
Supplementary Figure 1 from Restoring Retinoic Acid Attenuates Intestinal Inflammation and Tumorigenesis in APCMin/+ Mice
Authors: Penny Hweixian Leong , Prestwood Tyler R. , Bhattacharya Nupur , Sun Fionna , Kenkel Justin A. , Davidson Matthew G. , Shen Lei , Zuniga Luis A. , Seeley E. Scott , Pai Reetesh , Choi Okmi , Tolentino Lorna , Wang Jinshan , Napoli Joseph L. , Engleman Edgar G.
Published: April 2023

beta-catenin, RA metabolic enzymes, retinyl esters, all-trans retinol and RA in APCMin/+ tissues.
Supplementary Figures 1 through 16 and Supplementary Tables 1 through 3 from Myeloid STAT3 Promotes Lung Tumorigenesis by Transforming Tumor Immunosurveillance into Tumor-Promoting Inflammation
Authors: Zhou Jingjiao , Qu Zhaoxia , Sun Fan , Han Lei , Li Liwen , Yan Shapei , Stabile Laura P. , Chen Lin-Feng , Siegfried Jill M. , Xiao Gutian
Published: April 2023

Supplementary Figure S1. Decreased survival rate of lung cancer patients who are older than 65 and with high STAT3 activation in TAMs Supplementary Figure S2. STAT3 knockout in myeloid cells in STAT3DMye mice Supplementary Figure S3. STAT3 knockout in myeloid cells in STAT3DMye mice Supplementary Figure S4. Decreased lung tumorigenesis in urethane-treated STAT3DMye mice Supplementary Figure S5. Same pathology of the lung tumors in WT and STAT3DMye mice treated with urethane Supplementary Figure S6. Different changes in the total numbers of lung macrophages, neutrophils and lymphocytes in urethane-treated STAT3DMyc mice Supplementary Figure S7. Increased M1 macrophages but decreased M2 macrophages in the lungs of urethane-treated STAT3DMye mice Supplementary Figure S8. Lung myeloid and lymphoid cell changes in STAT3DMye mice treated with urethane Supplementary Figure S9. Expression changes of chemokines in mouse lungs by urethane Supplementary Figure S10. T-cell apoptosis by MDSCs Supplementary Figure S11. Defect in T-cell apoptosis induction by STAT3 KO macrophages Supplementary Figure S12. No obvious effect on T-cell proliferation and lung recruitment by myeloid STAT3 deletion Supplementary Figure S13. Treg cell differentiation by WT macrophages but not by STAT3 KO macrophages Supplementary Figure S14. Reversal of the decreased lung tumorigenesis in urethane-treated STAT3DMye mice by CD8 deletion Supplementary Figure S15. Quantification of the iNOS and arginase staining in the Figure 7F Supplementary Figure S16. Reduced STAT3 activation in lung tumor cells in STAT3DMye mice Supplementary Table S1. Antibodies used in this study Supplementary Table S2. Clinicopathological characteristics of lung cancer patients Supplementary Table S3. Primer pairs used for real-time PCR in the study
Supplementary Materials and Methods from Generation of Mouse Pluripotent Stem Cell–Derived Proliferating Myeloid Cells as an Unlimited Source of Functional Antigen-Presenting Cells
Authors: Zhang Rong , Liu Tian-Yi , Senju Satoru , Haruta Miwa , Hirosawa Narumi , Suzuki Motoharu , Tatsumi Minako , Ueda Norihiro , Maki Hiroyuki , Nakatsuka Ryusuke , Matsuoka Yoshikazu , Sasaki Yutaka , Tsuzuki Shinobu , Nakanishi Hayao , Araki Ryoko , Abe Masumi , Akatsuka Yoshiki , Sakamoto Yasushi , Sonoda Yoshiaki , Nishimura Yasuharu , Kuzushima Kiyotaka , Uemura Yasushi
Published: April 2023

Supplementary Materials and Methods
Supplementary Figure Legends from Generation of Mouse Pluripotent Stem Cell–Derived Proliferating Myeloid Cells as an Unlimited Source of Functional Antigen-Presenting Cells
Authors: Zhang Rong , Liu Tian-Yi , Senju Satoru , Haruta Miwa , Hirosawa Narumi , Suzuki Motoharu , Tatsumi Minako , Ueda Norihiro , Maki Hiroyuki , Nakatsuka Ryusuke , Matsuoka Yoshikazu , Sasaki Yutaka , Tsuzuki Shinobu , Nakanishi Hayao , Araki Ryoko , Abe Masumi , Akatsuka Yoshiki , Sakamoto Yasushi , Sonoda Yoshiaki , Nishimura Yasuharu , Kuzushima Kiyotaka , Uemura Yasushi
Published: April 2023

Supplementary Figure Legends
Supplementary Table S1 from Whole Exome and Transcriptome Analyses Integrated with Microenvironmental Immune Signatures of Lung Squamous Cell Carcinoma
Authors: Seo Jeong-Sun , Lee Ji Won , Kim Ahreum , Shin Jong-Yeon , Jung Yoo Jin , Lee Sae Bom , Kim Yoon Ho , Park Samina , Lee Hyun Joo , Park In-Kyu , Kang Chang-Hyun , Yun Ji-Young , Kim Jihye , Kim Young Tae
Published: April 2023

The clinical features of 101 LUSC patients enrolled in this study.
Supplementary Figures S1-S4 and Table S1 from PD-L1 Binds to B7-1 Only In Cis on the Same Cell Surface
Authors: Chaudhri Apoorvi , Xiao Yanping , Klee Alyssa N. , Wang Xiaoxu , Zhu Baogong , Freeman Gordon J.
Published: April 2023

Supplementary Figures S1-S4 and Table S1
Supplementary Table from Selective Targeting of Glioblastoma with EGFRvIII/EGFR Bitargeted Chimeric Antigen Receptor T Cell
Authors: Jiang Hua , Gao Huiping , Kong Juan , Song Bo , Wang Peng , Shi Bizhi , Wang Huamao , Li Zonghai
Published: April 2023

Table S1
Supplementary Figures and Legends from LncRNA-MM2P Identified as a Modulator of Macrophage M2 Polarization
Authors: Cao Ji , Dong Rong , Jiang Li , Gong Yanling , Yuan Meng , You Jieqiong , Meng Wen , Chen Zhanlei , Zhang Ning , Weng Qinjie , Zhu Hong , He Qiaojun , Ying Meidan , Yang Bo
Published: April 2023

Supplementary figures and figure legends
Supplementary Figure and Table Captions from Enhancement of Peptide Vaccine Immunogenicity by Increasing Lymphatic Drainage and Boosting Serum Stability
Authors: Moynihan Kelly D. , Holden Rebecca L. , Mehta Naveen K. , Wang Chensu , Karver Mark R. , Dinter Jens , Liang Simon , Abraham Wuhbet , Melo Mariane B. , Zhang Angela Q. , Li Na , Gall Sylvie Le , Pentelute Bradley L. , Irvine Darrell J.
Published: April 2023

Captions for Supplementary Figures and Supplementary Table
Supplementary Figure S5 from Enhancement of Peptide Vaccine Immunogenicity by Increasing Lymphatic Drainage and Boosting Serum Stability
Authors: Moynihan Kelly D. , Holden Rebecca L. , Mehta Naveen K. , Wang Chensu , Karver Mark R. , Dinter Jens , Liang Simon , Abraham Wuhbet , Melo Mariane B. , Zhang Angela Q. , Li Na , Gall Sylvie Le , Pentelute Bradley L. , Irvine Darrell J.
Published: April 2023

Supplementary Figure S5
Supplementary Figure S2 from Enhancement of Peptide Vaccine Immunogenicity by Increasing Lymphatic Drainage and Boosting Serum Stability
Authors: Moynihan Kelly D. , Holden Rebecca L. , Mehta Naveen K. , Wang Chensu , Karver Mark R. , Dinter Jens , Liang Simon , Abraham Wuhbet , Melo Mariane B. , Zhang Angela Q. , Li Na , Gall Sylvie Le , Pentelute Bradley L. , Irvine Darrell J.
Published: April 2023

Supplementary Figure S2
Supplementary Figure S1 from Enhancement of Peptide Vaccine Immunogenicity by Increasing Lymphatic Drainage and Boosting Serum Stability
Authors: Moynihan Kelly D. , Holden Rebecca L. , Mehta Naveen K. , Wang Chensu , Karver Mark R. , Dinter Jens , Liang Simon , Abraham Wuhbet , Melo Mariane B. , Zhang Angela Q. , Li Na , Gall Sylvie Le , Pentelute Bradley L. , Irvine Darrell J.
Published: April 2023

Supplementary Figure S1
SupplementaryTable S4 from Quantitative Analysis of Immune Infiltrates in Primary Melanoma
Authors: Gartrell Robyn D. , Marks Douglas K. , Hart Thomas D. , Li Gen , Davari Danielle R. , Wu Alan , Blake Zoë , Lu Yan , Askin Kayleigh N. , Monod Anthea , Esancy Camden L. , Stack Edward C. , Jia Dan Tong , Armenta Paul M. , Fu Yichun , Izaki Daisuke , Taback Bret , Rabadan Raul , Kaufman Howard L. , Drake Charles G. , Horst Basil A. , Saenger Yvonne M.
Published: April 2023

Supplementary Pearson Correlation Matrix
Supplementary Table S3 from Quantitative Analysis of Immune Infiltrates in Primary Melanoma
Authors: Gartrell Robyn D. , Marks Douglas K. , Hart Thomas D. , Li Gen , Davari Danielle R. , Wu Alan , Blake Zoë , Lu Yan , Askin Kayleigh N. , Monod Anthea , Esancy Camden L. , Stack Edward C. , Jia Dan Tong , Armenta Paul M. , Fu Yichun , Izaki Daisuke , Taback Bret , Rabadan Raul , Kaufman Howard L. , Drake Charles G. , Horst Basil A. , Saenger Yvonne M.
Published: April 2023

Supplementary ROC Curve and Univariable Cox results
Supplementary Table S1 from Quantitative Analysis of Immune Infiltrates in Primary Melanoma
Authors: Gartrell Robyn D. , Marks Douglas K. , Hart Thomas D. , Li Gen , Davari Danielle R. , Wu Alan , Blake Zoë , Lu Yan , Askin Kayleigh N. , Monod Anthea , Esancy Camden L. , Stack Edward C. , Jia Dan Tong , Armenta Paul M. , Fu Yichun , Izaki Daisuke , Taback Bret , Rabadan Raul , Kaufman Howard L. , Drake Charles G. , Horst Basil A. , Saenger Yvonne M.
Published: April 2023

Demographics for Unanalyzable Cohort
Supplemental Table S1-4 and Supplemental Figure S1-S7 from Quantitative Analysis of Immune Infiltrates in Primary Melanoma
Authors: Gartrell Robyn D. , Marks Douglas K. , Hart Thomas D. , Li Gen , Davari Danielle R. , Wu Alan , Blake Zoë , Lu Yan , Askin Kayleigh N. , Monod Anthea , Esancy Camden L. , Stack Edward C. , Jia Dan Tong , Armenta Paul M. , Fu Yichun , Izaki Daisuke , Taback Bret , Rabadan Raul , Kaufman Howard L. , Drake Charles G. , Horst Basil A. , Saenger Yvonne M.
Published: April 2023

Supplemental Figure 1: Flow chart for database Supplemental Figure 2: Representation of Tissue segmentation Supplemental Figure 3: Representation of Cell Segmentation Supplemental Figure 4: Representation of Phenotyping Supplemental Figure 5: Representation of Scoring Supplemental Figure 6: Supplementary Distance and Survival Data Supplementary ROC Curve and Univariable Cox results Supplemental Figure S7: ROC curve for 2y and 5y DSS
Supplementary Figure Legends from Anti–CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor Control
Authors: Sanseviero Emilio , O’Brien Erin M. , Karras Jenna R. , Shabaneh Tamer B. , Aksoy Bulent Arman , Xu Wei , Zheng Cathy , Yin Xiangfan , Xu Xiaowei , Karakousis Giorgos C. , Amaravadi Ravi K. , Nam Brian , Turk Mary Jo , Hammerbacher Jeff , Rubinstein Mark P. , Schuchter Lynn M. , Mitchell Tara C. , Liu Qin , Stone Erica L.
Published: April 2023

Supplementary Figure Legends for S1-4
Supplementary Figure 3 from Anti–CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor Control
Authors: Sanseviero Emilio , O’Brien Erin M. , Karras Jenna R. , Shabaneh Tamer B. , Aksoy Bulent Arman , Xu Wei , Zheng Cathy , Yin Xiangfan , Xu Xiaowei , Karakousis Giorgos C. , Amaravadi Ravi K. , Nam Brian , Turk Mary Jo , Hammerbacher Jeff , Rubinstein Mark P. , Schuchter Lynn M. , Mitchell Tara C. , Liu Qin , Stone Erica L.
Published: April 2023

Supplementary Figure 3
Supplementary Figure 2 from Anti–CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor Control
Authors: Sanseviero Emilio , O’Brien Erin M. , Karras Jenna R. , Shabaneh Tamer B. , Aksoy Bulent Arman , Xu Wei , Zheng Cathy , Yin Xiangfan , Xu Xiaowei , Karakousis Giorgos C. , Amaravadi Ravi K. , Nam Brian , Turk Mary Jo , Hammerbacher Jeff , Rubinstein Mark P. , Schuchter Lynn M. , Mitchell Tara C. , Liu Qin , Stone Erica L.
Published: April 2023

Supplementary Figure 2
Supplementary Figure 1 from Anti–CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor Control
Authors: Sanseviero Emilio , O’Brien Erin M. , Karras Jenna R. , Shabaneh Tamer B. , Aksoy Bulent Arman , Xu Wei , Zheng Cathy , Yin Xiangfan , Xu Xiaowei , Karakousis Giorgos C. , Amaravadi Ravi K. , Nam Brian , Turk Mary Jo , Hammerbacher Jeff , Rubinstein Mark P. , Schuchter Lynn M. , Mitchell Tara C. , Liu Qin , Stone Erica L.
Published: April 2023

Supplementary Figure 1